In selecting these promising innovations, the authors examined the evidence of their effects on cost and quality-of-care.
The innovations are sorted into three groups based on evidence for their potential benefits.
Transformation in health care takes time.
Bids are evaluated based on the suppliers eligibility and financial stability, as well as the bid price.
The program was temporarily suspended in 2019 while the Medicare agency reviews the bidding process.
In one-sided risk models, ACOs receive a portion of any savings they generate.
The support comes in monthly, per-patient amounts from Medicare and the partnering payers.
Group Three: One innovation that meritscautious optimismbut requires more thorough evaluation for determine its potential.
In other bundled payment initiatives, hospitals and other providers may opt to voluntarily participate.
That decision is now pending appeal.
